Compare Viemed Healthcare, Inc. with Similar Stocks
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
15.95%
EBIT Growth (5y)
0.10%
EBIT to Interest (avg)
17.50
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
1.56
Tax Ratio
28.83%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
75.23%
ROCE (avg)
19.50%
ROE (avg)
15.81%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.90
EV to EBIT
15.11
EV to EBITDA
5.85
EV to Capital Employed
2.01
EV to Sales
1.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.29%
ROE (Latest)
10.31%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 41 Schemes (22.99%)
Foreign Institutions
Held by 53 Foreign Institutions (8.71%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
71.90
63.10
13.95%
Operating Profit (PBDIT) excl Other Income
14.50
11.40
27.19%
Interest
0.50
0.10
400.00%
Exceptional Items
-0.80
-0.10
-700.00%
Consolidate Net Profit
3.60
3.30
9.09%
Operating Profit Margin (Excl OI)
96.90%
71.60%
2.53%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 13.95% vs 6.77% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is 9.09% vs 22.22% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
224.30
183.00
22.57%
Operating Profit (PBDIT) excl Other Income
40.30
37.40
7.75%
Interest
0.80
0.40
100.00%
Exceptional Items
-0.40
-0.10
-300.00%
Consolidate Net Profit
11.40
10.20
11.76%
Operating Profit Margin (Excl OI)
72.90%
84.80%
-1.19%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 22.57% vs 31.84% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 11.76% vs 64.52% in Dec 2023






